Best of Biotech Competition: CeMM researchers among the best 10 teams
“Best of Biotech” is an international life science business plan competition organized by Life Science Austria (LISA), a program run by the Austria Wirtschaftsservice (AWS) on behalf of the Austrian Federal Ministry of Science, Research and Economy. On May 6, 2015 an international jury consisting of distinguished experts from the areas of science, industry and finance selected the winners of the competition.
CeMM congratulates its researchers for being among the top 10 teams in the “Best of Biotech” competition out of 42 applications from 11 different countries.
The project idea: During the management of patients with blood cancers,…
Open Statement in support of opposing the cuts in the EU budget earmarked for research
EU-LIFE strongly supports the position of the European Parliament against H2020 cuts and now urges the EU Commission to substantially amend the EFSI (European Fund for Strategic Investments) proposal to ensure full protection of the EU budget for research; and the support of Member States Governments to ensure this protection.
In particular, we call for the following measures:
1. Stop deviating funds from research. Science must be protected if Europe wants to be a leading economy. In particular:
a. It is not acceptable to deviate funds from the thoroughly negotiated and validated H2020 budget to beneficiate a yet unproven mechanism to…
Karl Landsteiner Lecture 2015
Stressed Out: A Novel Approach to Cancer Immunotherapy
One target – two anti-cancer strategies!
On April 27th Laurie H. Glimcher, Dean of Weill Cornell Medical College delivered this year’s CeMM Landsteiner Lecture with the topic “Stressed Out: A Novel Approach to Cancer Immunotherapy”. In her lively and fascinating talk, Laurie H. Glimcher presented a novel approach to cancer immunotherapy that looks promising to treat solid, very aggressive, and unfortunately often late diagnosed tumors like breast or ovarian cancer. Her talk attracted more than 300 people to the Festive Hall of the Austrian Academy of Sciences, among them institute…
SMART lecture – Peter Brabeck-Letmathe
On March 16th, 2015, the 4th SMART Lecture was delivered by Peter Brabeck-Letmathe, Chairman of the Board of Nestlé S.A. The topic “Big Data Challenges and Opportunities for Food and Nutritional Sciences” attracted an audience of some 150 people, among them scientists, students and interested visitors. CeMM’s PhD Students obtained the chance to meet the Austrian businessman with an exceptional career in an industry branch confronted with major societal responsibility challenges in a closed Q&A session prior to his public lecture.
In his talk, Dr. Brabeck-Letmathe stated Nestlé´s position as a worldwide player in the food industry slowly…
Researchers at CeMM have developed a method for studying DNA methylation in single cells
Dissecting the human epigenome one cell at a time
Every human life starts from a single cell. This cell, the zygote, undergoes many rounds of cell division and epigenome remodeling as it gives rise to the different cell types in the human body. Each organ of our body comprises a handful of cell types that serve specific biological functions. But there is often significant variation between single cells of the same type. Such cell-to-cell differences become particularly relevant in cancer, when a single cell that is by chance resistant to chemotherapy can become the “winner” of massive evolutionary selection in response to therapy, which can…
Read more
Strengthening the partnership and cooperation between CeMM and the Medical University
Giulio Superti-Furga takes over the professorship for Medical Systems Biology at the Medical University of Vienna. The Scientific Director of CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences was previously a Visiting Professor of Molecular Pharmacology at the Medical University of Vienna. At the same time Sylvia Knapp, Professor of Infection Biology at the Medical University of Vienna and Principal Investigator at CeMM takes over the newly created position of Director of Medical Affairs at CeMM.
Superti-Furga is a strong proponent of systems biology approaches in medicine and drug research with the aim to…
Researchers at the CeMM in Vienna have unearthened an unexpected new target for Triple Negative Breast Cancers
Breast cancer is clinically subdivided into receptor positive or negative tumors, (also known as triple negative breast cancer). Receptor positivity indicates a better prognosis as several specific agents to treat these tumors are available. Such agents, however, have been lacking for receptor negative tumors. To try to identify new agents that would specifically kill triple negative breast cancer cells, a team led by CeMM Principal Investigator Sebastian Nijman conducted a large chemical screen. They used carefully engineered breast cell lines that mimic triple negative breast cancer cells and systematically tested over 20 thousand…
European Research Council grants: Good news for EU-LIFE centres, but with a bitter aftertaste
EU-LIFE European research centres obtained 14 new ERC Starting and Consolidator grants in the latest competitions, which takes the total of ERC-funded grants currently running in centres belonging to the alliance to over 100. As a whole, EU-LIFE partners have a success rate of at least three times higher than the general success rate of ERC Starting and Consolidator grants (over 33% compared to an average of 10%). But this news comes with a bitter aftertaste, as the announced cuts in the Horizon 2020 budget (including ERC) due to the so-called Juncker’s plan may now jeopardise Europe’s competitiveness in future research and innovation.
Read more
The 2015 CeMM PhD Program - Apply Now!
The 2015 CeMM PhD Program is now open for applications. For our next program starting in October 2015 we are looking for exceptionally motivated PhD candidates with a keen interest in genomics and medicine and an ability and desire to work in a team.
The 2015 CeMM PhD program will focus on two thematic areas: infection and cancer. These thematic areas are built on the pillars of epigenetics, bioinformatics and systems biology, chemical biology and the mechanism of action of drugs, high-throughput genetics, genomics and proteomics, and molecular and cell biology. Future CeMM PhD students will have an opportunity to work at the cutting edge…
2015 CeMM PhD Program - Apply Now
The 2015 CeMM PhD Program is now open for applications. For our next program starting in October 2015 we are looking for exceptionally motivated PhD candidates with a keen interest in genomics and medicine and an ability and desire to work in a team.
The 2015 CeMM PhD program will focus on two thematic areas: infection and cancer. These thematic areas are built on the pillars of epigenetics, bioinformatics and systems biology, chemical biology and the mechanism of action of drugs, high-throughput genetics, genomics and proteomics, and molecular and cell biology. Future CeMM PhD students will have an opportunity to work at the cutting edge…